Adhesion molecule periplakin is involved in cellular movement and attachment in pharyngeal squamous cancer cells

BMC Cell Biology

Volumn 12, Issue , 2011, Pages

  Tonoike, Yurie ^a   Matsushita, Kazuyuki ^a   Tomonaga, Takeshi ^a,b   Katada, Koji ^a   Tanaka, Nobuko ^a   Shimada, Hideaki ^c   Nakatani, Yukio ^d   Okamoto, Yoshitaka ^a   Nomura, Fumio ^a  

^a CHIBA UNIVERSITY HOSPITAL   (Japan)

^b NATIONAL INSTITUTE OF BIOMEDICAL INNOVATION   (Japan)

^c TOHO UNIVERSITY OMORI MEDICAL CENTER   (Japan)

^d CHIBA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; CELL ADHESION MOLECULE; PERIPLAKIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; SERINE; SMALL INTERFERING RNA; 2-(4-MORPHOLINYL)-8-PHENYL-4H-1-BENZOPYRAN-4-ONE; AKT3 PROTEIN, HUMAN; CHROMONE DERIVATIVE; MORPHOLINE DERIVATIVE; PLAKIN; PPL PROTEIN, HUMAN;

ARTICLE; CARCINOGENESIS; CARCINOMA CELL; CELL ADHESION; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL GROWTH; CELL MIGRATION; CELL MOTION; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; PHARYNX CANCER; PROTEIN DEPHOSPHORYLATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SQUAMOUS CELL CARCINOMA; TUMOR GROWTH; CELL CYCLE; DRUG ANTAGONISM; DRUG EFFECT; GENETICS; METABOLISM; PATHOLOGY; PHOSPHORYLATION; TUMOR CELL LINE;

CARCINOMA, SQUAMOUS CELL; CELL ADHESION; CELL CYCLE; CELL GROWTH PROCESSES; CELL LINE, TUMOR; CELL MOVEMENT; CHROMONES; HUMANS; MORPHOLINES; PHARYNGEAL NEOPLASMS; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHORYLATION; PLAKINS; PROTO-ONCOGENE PROTEINS C-AKT; RNA, SMALL INTERFERING;

EID: 80053349811     PISSN: None     EISSN: 14712121     Source Type: Journal    
DOI: 10.1186/1471-2121-12-41     Document Type: Article

References (38)

1. Daly JM, Karnell LH, Menck HR. National Cancer Data Base report on esophageal carcinoma. Cancer 1996, 78:1820-8. 10.1002/(SICI)1097-0142(19961015)78:8<1820::AID-CNCR25>3.0.CO;2-Z, 8859198.
2. Nishimori T, Tomonaga T, Matsushita K, Oh-Ishi M, Kodera Y, Maeda T, Nomura F, Matsubara H, Shimada H, Ochiai T. Proteomic analysis of primary esophageal squamous cell carcinoma reveals downregulation of a cell adhesion protein, periplakin. Proteomics 2006, 6:1011-8. 10.1002/pmic.200500262, 16400690.
3. Hatakeyama H, Kondo T, Fujii K, Nakanishi Y, Kato H, Fukuda S, Hirohashi S. Protein clusters associated with carcinogenesis, histological differentiation and nodal metastasis in esophageal cancer. Proteomics 2006, 6:6300-16. 10.1002/pmic.200600488, 17133371.
4. Sonnenberg A, Liem RK. Plakins in development and disease. Exp Cell Res 2007, 313:2189-203. 10.1016/j.yexcr.2007.03.039, 17499243.
5. Lunter PC, Wiche G. Direct binding of plectin to Fer kinase and negative regulation of its catalytic activity. Biochem Biophys Res Commun 2002, 296:904-10. 10.1016/S0006-291X(02)02007-7, 12200133.
6. Gregor M, Zeold A, Oehler S, Marobela KA, Fuchs P, Weigel G, Hardie DG, Wiche G. Plectin scaffolds recruit energy-controlling AMP-activated protein kinase (AMPK) in differentiated myofibres. J Cell Sci 2006, 119:1864-75. 10.1242/jcs.02891, 16608880.
7. van den Heuvel AP, de Vries-Smits AM, van Weeren PC, Dijkers PF, de Bruyn KM, Riedl JA, Burgering BM. Binding of protein kinase B to the plakin family member periplakin. J Cell Sci 2002, 115:3957-66. 10.1242/jcs.00069, 12244133.
8. Larue L, Bellacosa A. Epithelial-mesenchymal transition in development and cancer: role of phosphatidylinositol 3' kinase/AKT pathways. Oncogene 2005, 24:7443-54. 10.1038/sj.onc.1209091, 16288291.
9. Hunton DL, Barnes WG, Kim J, Ren XR, Violin JD, Reiter E, Milligan G, Patel DD, Lefkowitz RJ. Beta-arrestin 2-dependent angiotensin II type 1A receptor-mediated pathway of chemotaxis. Mol Pharmacol 2005, 67:1229-36. 10.1124/mol.104.006270, 15635042.
10. Naga Prasad SV, Jayatilleke A, Madamanchi A, Rockman HA. Protein kinase activity of phosphoinositide 3-kinase regulates beta-adrenergic receptor endocytosis. Nat Cell Biol 2005, 7:785-96. 10.1038/ncb1278, 16094730.
11. Sun Y, Cheng Z, Ma L, Pei G. Beta-arrestin2 is critically involved in CXCR4-mediated chemotaxis, and this is mediated by its enhancement of p38 MAPK activation. J Biol Chem 2002, 277:49212-9. 10.1074/jbc.M207294200, 12370187.
12. Francke F, Ward RJ, Jenkins L, Kellett E, Richter D, Milligan G, Bachner D. Interaction of neurochondrin with the melanin-concentrating hormone receptor 1 interferes with G protein-coupled signal transduction but not agonist-mediated internalization. J Biol Chem 2006, 281:32496-507. 10.1074/jbc.M602889200, 16945926.
13. Murdoch H, Feng GJ, Bachner D, Ormiston L, White JH, Richter D, Milligan G. Periplakin interferes with G protein activation by the melanin-concentrating hormone receptor-1 by binding to the proximal segment of the receptor C-terminal tail. J Biol Chem 2005, 280:8208-20.
14. Ward RJ, Jenkins L, Milligan G. Selectivity and functional consequences of interactions of family A G protein-coupled receptors with neurochondrin and periplakin. J Neurochem 2009, 109:182-92.
15. Boczonadi V, McInroy L, Maatta A. Cytolinker cross-talk: periplakin N-terminus interacts with plectin to regulate keratin organisation and epithelial migration. Exp Cell Res 2007, 313:3579-91. 10.1016/j.yexcr.2007.07.005, 17662978.
16. Long HA, Boczonadi V, McInroy L, Goldberg M, Maatta A. Periplakin-dependent re-organisation of keratin cytoskeleton and loss of collective migration in keratin-8-downregulated epithelial sheets. J Cell Sci 2006, 119:5147-59. 10.1242/jcs.03304, 17158917.
17. Hong KO, Kim JH, Hong JS, Yoon HJ, Lee JI, Hong SP, Hong SD. Inhibition of Akt activity induces the mesenchymal-to-epithelial reverting transition with restoring E-cadherin expression in KB and KOSCC-25B oral squamous cell carcinoma cells. J Exp Clin Cancer Res 2009, 28:28-38. 10.1186/1756-9966-28-28, 2651854, 19243631.
18. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000, 100:57-70. 10.1016/S0092-8674(00)81683-9, 10647931.
19. Perez-Moreno M, Jamora C, Fuchs E. Sticky business: orchestrating cellular signals at adherens junctions. Cell 2003, 112:535-48. 10.1016/S0092-8674(03)00108-9, 12600316.
20. Silva JM, Ezhkova E, Silva J, Heart S, Castillo M, Campos Y, Castro V, Bonilla F, C. Cyfip1 is a putative invasion suppressor in epithelial cancers. Cell 2009, 137:1047-61. 10.1016/j.cell.2009.04.013, 2754270, 19524508.
21. Daouti S, Li WH, Qian H, Huang KS, Holmgren J, Levin W, Reik L, McGady DL, Gillespie P, Perrotta A, Bian H, Reidhaar-Olson JF, Bliss AR, Olivier JA, Sergi D, Fry W, Danho S, Ritland N, Fotouhi SA, Heimbrook D, Niu H. A selective phosphatase of regenerating liver phosphatase inhibitor suppresses tumor cell anchorage-independent growth by a novel mechanism involving p130Cas cleavage. Cancer Res 2008, 68:1162-9. 10.1158/0008-5472.CAN-07-2349, 18281492.
22. Guarino M, Rubino B, Ballabio G. The role of epithelial-mesenchymal transition in cancer pathology. Pathology 2007, 39:305-18. 10.1080/00313020701329914, 17558857.
23. Enomoto A, Murakami H, Asai N, Morone N, Watanabe T, Kawai K, Murakumo Y, Usukura J, Kaibuchi K, Takahashi M. Akt/PKB regulates actin organization and cell motility via Girdin/APE. Dev Cell 2005, 9:389-402. 10.1016/j.devcel.2005.08.001, 16139227.
24. Enomoto A, Ping J, Takahashi M. Girdin, a novel actin-binding protein, and its family of proteins possess versatile functions in the Akt and Wnt signaling pathways. Ann N Y Acad Sci 2006, 1086:169-84. 10.1196/annals.1377.016, 17185515.
25. Kim EK, Yun SJ, Ha JM, Kim YW, Jin IH, Yun J, Shin HK, Song SH, Kim JH, Lee JS, Kim CD, Bae SS. Selective activation of Akt1 by mammalian target of rapamycin complex 2 regulates cancer cell migration, invasion, and metastasis. Oncogene 2011, 30:2954-63. 10.1038/onc.2011.22, 21339740.
26. Karam AK, Santiskulvong C, Fekete M, Zabih S, Eng C, Dorigo O. Cisplatin and PI3kinase inhibition decrease invasion and migration of human ovarian carcinoma cells and regulate matrix-metalloproteinase expression. Cytoskeleton 2010, 67:535-544. 3001291, 20607860.
27. Giancotti FG, Ruoslahti E. Integrin signaling. Science 1999, 285:1028-32. 10.1126/science.285.5430.1028, 10446041.
28. Bhattacharya R, Gonzalez AM, Debiase PJ, Trejo HE, Goldman RD, Flitney FW, Jones JC. Recruitment of vimentin to the cell surface by beta3 integrin and plectin mediates adhesion strength. J Cell Sci 2009, 122:1390-400. 10.1242/jcs.043042, 2721003,2721003, 19366731.
29. Kazerounian S, Uitto J, Aho S. Unique role for the periplakin tail in intermediate filament association: specific binding to keratin 8 and vimentin. Exp Dermatol 2002, 11:428-38. 10.1034/j.1600-0625.2002.110506.x, 12366696.
30. Jinka R, Kapoor R, Pavuluri S, Thatipalli AR, Jerald MK, Rao L, Pande G. Differential gene expression and clonal selection during cellular transformation induced by adhesion deprivation. BMC Cell Biol 2010, 11:93-104. 10.1186/1471-2121-11-93, 3012028, 21122158.
31. Barnes EA, Kenerson HL, Jiang X, Yeung RS. Tuberin regulates E-cadherin localization: implications in epithelial-mesenchymal transition. Am J Pathol 2010, 177:1765-78. 10.2353/ajpath.2010.090233, 2947273, 20813961.
32. Jia LQ, Osada M, Ishioka C, Gamo M, Ikawa S, Suzuki T, Shimodaira H, Niitani T, Kudo T, Akiyama M, Kimura N, Matsuo M, Mizusawa H, Tanaka N, Namba M, Kanamaru R, Kuroki T. Screening the p53 status of human cell lines using a yeast functional assay. Mol Carcinog 1997, 19:243-53. 10.1002/(SICI)1098-2744(199708)19:4<243::AID-MC5>3.0.CO;2-D, 9290701.
33. Kajimoto T, Shirai Y, Sakai N, Yamamoto T, Matsuzaki H, Kikkawa U, Saito N. Ceramide-induced apoptosis by translocation, phosphorylation, and activation of protein kinase Cdelta in the Golgi complex. J Biol Chem 2004, 279:12668-76.
34. Iizuka N, Miyamoto K, Okita K, Tangoku A, Hayashi H, Yosino S, Abe T, Morioka T, Hazama S, Oka M. Inhibitory effect of Coptidis Rhizoma and berberine on the proliferation of human esophageal cancer cell lines. Cancer Lett 2000, 148:19-25. 10.1016/S0304-3835(99)00264-5, 10680588.
35. Cheng A, Solomon MJ. Speedy/Ringo C regulates S and G2 phase progression in human cells. Cell Cycle 2008, 7:3037-47. 10.4161/cc.7.19.6736, 2592538, 18802405.
36. Pelayo BA, Fu YM, Meadows GG. Decreased tissue plasminogen activator and increased plasminogen activator inhibitors and increased activator protein-1 and specific promoter 1 are associated with inhibition of invasion in human A375 melanoma deprived of tyrosine and phenylalanine. Int J Oncol 2001, 18:877-83.
37. Uhlenkott CE, Huijzer JC, Cardeiro DJ, Elstad CA, Meadows GG. Attachment, invasion, chemotaxis, and proteinase expression of B16-BL6 melanoma cells exhibiting a low metastatic phenotype after exposure to dietary restriction of tyrosine and phenylalanine. Clin Exp Metastasis 1996, 14:125-37. 10.1007/BF00121209, 8605726.
38. Matsushita K, Tomonaga T, Shimada H, Shioya A, Higashi M, Matsubara H, Harigaya K, Nomura F, Libutti D, Levens D, Ochiai T. An essential role of alternative splicing of c-myc suppressor FUSE-binding protein-interacting repressor in carcinogenesis. Cancer Res 2006, 66:1409-17. 10.1158/0008-5472.CAN-04-4459, 16452196.